JP2020535832A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535832A5 JP2020535832A5 JP2020519092A JP2020519092A JP2020535832A5 JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5 JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- tcr
- human
- antigen
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023220106A JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568339P | 2017-10-05 | 2017-10-05 | |
| US62/568,339 | 2017-10-05 | ||
| PCT/US2018/052432 WO2019070435A1 (en) | 2017-10-05 | 2018-09-24 | METHODS FOR SELECTIVE EXPANSION OF CELLS EXPRESSING A TCR WITH A CONSTANT MURINE REGION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Division JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020535832A JP2020535832A (ja) | 2020-12-10 |
| JP2020535832A5 true JP2020535832A5 (https=) | 2021-11-04 |
Family
ID=63841049
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519092A Pending JP2020535832A (ja) | 2017-10-05 | 2018-09-24 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12227554B2 (https=) |
| EP (2) | EP3692140B1 (https=) |
| JP (2) | JP2020535832A (https=) |
| KR (1) | KR102757789B1 (https=) |
| CN (1) | CN111417720B (https=) |
| AU (1) | AU2018345400B2 (https=) |
| CA (1) | CA3077595A1 (https=) |
| ES (1) | ES2960313T3 (https=) |
| FI (1) | FI3692140T3 (https=) |
| IL (1) | IL273698B2 (https=) |
| MA (1) | MA50748A (https=) |
| SG (1) | SG11202003112QA (https=) |
| WO (1) | WO2019070435A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220195006A1 (en) * | 2020-12-22 | 2022-06-23 | Neogene Therapeutics B.V. | Peptide markers to track genetically engineered cells |
| IL305393A (en) | 2021-02-25 | 2023-10-01 | Alaunos Therapeutics Inc | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| US20250145950A1 (en) | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1291360A1 (en) * | 1991-12-13 | 2003-03-12 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| JPH11512284A (ja) * | 1995-09-05 | 1999-10-26 | ザ ジェネラル ホスピタル コーポレイション | 単クローン性リンパ球及び利用方法 |
| DE19905048A1 (de) | 1999-02-08 | 2000-08-10 | Gsf Forschungszentrum Umwelt | Verwendung depletorisch oder mitogen wirkender Antikörper in der Immuntherapie |
| JP2003274960A (ja) | 2000-02-03 | 2003-09-30 | Japan Science & Technology Corp | 可溶性ｔ細胞受容体タンパク質およびその作成方法 |
| JP2003276960A (ja) * | 2002-03-26 | 2003-10-02 | Mitsubishi Electric Corp | エレベーター制御システム |
| AU2003265948B8 (en) | 2002-09-06 | 2009-09-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| US8772451B2 (en) * | 2003-11-10 | 2014-07-08 | Altor Bioscience Corporation | Soluble TCR molecules and methods of use |
| CA2651174A1 (en) * | 2006-05-03 | 2007-11-15 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Chimeric t cell receptors and related materials and methods of use |
| AU2008206442B2 (en) | 2007-01-12 | 2012-10-18 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | gp100-specific T cell receptors and related materials and methods of use |
| WO2010088160A1 (en) | 2009-01-28 | 2010-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| CN103124740B (zh) | 2010-09-21 | 2015-09-02 | 美国卫生和人力服务部 | 抗-ssx-2t细胞受体和相关材料及使用方法 |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| JP6378172B2 (ja) | 2012-05-22 | 2018-08-22 | アメリカ合衆国 | マウス抗ｎｙ−ｅｓｏ−１ｔ細胞受容体 |
| IL286786B (en) * | 2012-09-14 | 2022-09-01 | The Us Secretary Department Of Health And Human Services Office Of Technology Transfer National Inst | T cell receptors that recognize mhc mage–a3 are restricted type ii |
| CN110511960B (zh) * | 2013-07-15 | 2023-05-23 | 美国卫生和人力服务部 | 抗人乳头瘤病毒16 e6 t细胞受体 |
| IL290655B2 (en) * | 2014-05-29 | 2024-05-01 | Us Health | Anti-human papillomavirus 16 E7 T-cell chelates |
| US10973894B2 (en) * | 2014-10-02 | 2021-04-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human | Methods of isolating T cells having antigenic specificity for a cancer-specific mutation |
| WO2016079333A1 (en) * | 2014-11-20 | 2016-05-26 | Umc Utrecht Holding B.V. | Use of antibodies for enrichment of engineered t cells with exogenous immune receptors and antibodies for use in depletion of engineered t cells |
| MX384919B (es) | 2014-11-26 | 2025-03-14 | Us Health | Receptores de células t de kras anti-mutado. |
| JP7185524B2 (ja) | 2015-09-15 | 2022-12-07 | アメリカ合衆国 | Ｈｌａ－ｃｗ８拘束性の変異ｋｒａｓを認識するｔ細胞受容体 |
| WO2017189254A1 (en) | 2016-04-26 | 2017-11-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-kk-lc-1 t cell receptors |
| WO2018026691A1 (en) | 2016-08-02 | 2018-02-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-kras-g12d t cell receptors |
-
2018
- 2018-09-24 AU AU2018345400A patent/AU2018345400B2/en active Active
- 2018-09-24 CA CA3077595A patent/CA3077595A1/en active Pending
- 2018-09-24 US US16/652,948 patent/US12227554B2/en active Active
- 2018-09-24 IL IL273698A patent/IL273698B2/en unknown
- 2018-09-24 CN CN201880076862.9A patent/CN111417720B/zh active Active
- 2018-09-24 WO PCT/US2018/052432 patent/WO2019070435A1/en not_active Ceased
- 2018-09-24 JP JP2020519092A patent/JP2020535832A/ja active Pending
- 2018-09-24 MA MA050748A patent/MA50748A/fr unknown
- 2018-09-24 EP EP18786145.5A patent/EP3692140B1/en active Active
- 2018-09-24 KR KR1020207012314A patent/KR102757789B1/ko active Active
- 2018-09-24 FI FIEP18786145.5T patent/FI3692140T3/fi active
- 2018-09-24 EP EP23185846.5A patent/EP4269595A3/en active Pending
- 2018-09-24 ES ES18786145T patent/ES2960313T3/es active Active
- 2018-09-24 SG SG11202003112QA patent/SG11202003112QA/en unknown
-
2023
- 2023-12-26 JP JP2023220106A patent/JP7747724B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kervevan et al. | Role of CD4+ T cells in the control of viral infections: recent advances and open questions | |
| Selck et al. | Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation | |
| Agac et al. | Host responses to respiratory syncytial virus infection | |
| Palatella et al. | The dark side of Tregs during aging | |
| JP2021511790A5 (https=) | ||
| JP2016539929A5 (https=) | ||
| JP2023164900A5 (https=) | ||
| JP2019536461A5 (https=) | ||
| JP2016509840A5 (https=) | ||
| JP2020535832A5 (https=) | ||
| JP2019516754A5 (https=) | ||
| JP2004536615A5 (https=) | ||
| Qiu et al. | Listeria monocytogenes: a model pathogen continues to refine our knowledge of the CD8 T cell response | |
| JP2010505830A5 (https=) | ||
| WO2016165632A1 (zh) | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 | |
| JP2018522072A5 (https=) | ||
| CN102911918A (zh) | 一种基因工程细胞及其在nk细胞扩增中的应用 | |
| JP2012505665A5 (https=) | ||
| JP2011519869A5 (https=) | ||
| ATE525908T1 (de) | Einstufiges schnellverfahren zurherstellung eines antigenbeladenen dendritenzellimpfstoffs aus vorstufen | |
| JP2017508523A5 (https=) | ||
| JP2013505296A5 (https=) | ||
| DE60332377D1 (de) | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden | |
| JP2012508575A5 (https=) | ||
| Kristoff et al. | Role of dendritic cells in exposing latent HIV-1 for the kill |